Clinical Trial Update: A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 safety study of bimatoprost in patients with glaucoma or ocular hypertension has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost (bimatoprost)
• Lumigan (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-05-06